[ad_1]
Dublin, December 30, 2021 /PRNewswire/– “ADME Toxicology Testing Market: Global Industry Trends, Share, Scale, Growth, Opportunities and Forecasts 2021-2026” Report has been added to ResearchAndMarkets.com supply.
From 2015 to 2020, the compound annual growth rate of the global ADME toxicology test market is approximately 13%.
Absorption, Distribution, Metabolism, and Excretion (ADME) Toxicology testing is conducted in the early stages of the drug development process to determine the safety, absorption, elimination, effectiveness, and metabolic behavior of the parent compound or drug in the organism.
It is usually carried out by researchers using software solutions, equipment, detectors, etc. in cell-based and in vitro assays to identify active compounds, genetic interactions, and other biomolecular interactions.
It helps to understand the safety and toxicity of drug candidates before entering post-clinical and clinical studies, thereby saving costs, drug discovery time and testing complications.
The increasing prevalence of diseases is increasing the demand for new drugs and biological products. This represents one of the key factors in adopting ADME toxicology testing to prevent drug candidates from failing in late-stage clinical trials.
It also helps researchers determine the feasibility of these drugs required for regulatory approval. In addition, one of the main trends witnessed in the market is that the U.S. Food and Drug Administration (FDA) has introduced several guidance documents to provide descriptions of the properties of ADME when assessing safety and effectiveness…
The full story on Benzinga.com
[ad_2]
Source link
